Bharat Immunologicals (India) Buy or Sell Recommendation

Macroaxis provides Bharat Immunologicals Biologicals Corp Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bharat Immunologicals positions. The advice algorithm takes into account all of Bharat Immunologicals Biologicals Corp Ltd available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Bharat Immunologicals buy-and-hold prospective. Check also Bharat Immunologicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon

  

Risk Tolerance

  
Symbol
Execute Advice
Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bharat Immunologicals Biologicals Corp Ltd is 'Strong Buy'.
For the selected time horizon Bharat Immunologicals Biologicals Corp Ltd has a risk adjusted performance of 0.1091, jensen alpha of 0.7112, total risk alpha of 0.2756, sortino ratio of 0.3328 and treynor ratio of 0.7219
Macroaxis buy, hold, or sell suggestion module can be used to complement Bharat Immunologicals buy, hold, or sell recommendation provided by average analyst sentiment. It analyzes the organization potential to grow using fundamental, technical, data market data available at the time. To make sure Bharat Immunologicals is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Total Debt, as well as the relationship between Price to Earning and Net Income .

Returns Distribution Density

Mean Return0.79Value At Risk-2.5478
Potential Upside9.5133Standard Deviation4.0274
 Return Density 
Benchmark  Embed    Distribution 

Bharat Immunologicals Greeks

α
Alpha over NYSE
= 0.71 
βBeta against NYSE= 1.08 
σ
Overall volatility
= 5.68 
 IrInformation ratio = 0.18 

Bharat Immunologicals Volatility Alert

Bharat Immunologicals Biologicals Corp Ltd currently demonstrates below average downside deviation of 2.15. It has Information Ratio of 0.18 and Jensen Alpha of 0.71. However, we do advice investors to further question Bharat Immunologicals Biologicals Corp Ltd expected returns to make sure all indicators are consistent with the current outlook about its relatively low value at risk.
    
 Better Than Average     
    
 Worse Than Average Compare Bharat Immunologicals to competition
FundamentalsBharat ImmunologicalsPeer Average
Return On Equity(11.52) % (15.17) %
Return On Asset(1.69) % (15.64) %
Profit Margin(4.18) % (5.50) %
Operating Margin(5.13) % (10.91) %
Current Valuation862.5 M152.14 B
Shares Outstanding43.18 M1.43 B
Price to Earning65.75 times40.69 times
Price to Book2.50 times14.44 times
Price to Sales0.66 times17.81 times
Revenue1.28 B9.85 B
Gross Profit119 M21.75 B
EBITDA(56.51 M)1.41 B
Net Income(53.46 M)517.71 M
Cash and Equivalents152.27 M3.89 B
Cash per Share3.55 times5.17 times
Total Debt177.56 M7.36 B
Debt to Equity0.50 times0.72 times
Current Ratio1.69 times3.30 times
Book Value Per Share8.21 times13.64 times
Earnings Per Share(1.24) times2.30 times
Number of Employees510.67 K
Market Capitalization844.17 M29.78 B
Z Score2.4708.73
SellBuy
Strong Buy

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Currently Unavailable

Financial Leverage

Inapplicable
Risk Adjusted Performance0.1091
Market Risk Adjusted Performance0.7319
Mean Deviation2.62
Semi Deviation1.4
Downside Deviation2.15
Coefficient Of Variation509.46
Standard Deviation4.03
Variance16.22
Information Ratio0.1779
Jensen Alpha0.7112
Total Risk Alpha0.2756
Sortino Ratio0.3328
Treynor Ratio0.7219
Maximum Drawdown17.96
Value At Risk(2.55)
Potential Upside9.51
Downside Variance4.64
Semi Variance1.95
Expected Short fall(4.27)
Skewness2.06
Kurtosis4.65